Abstract | BACKGROUND AND AIMS: METHODS: The -201 SNP in IP-10 promoter was genotyped from 577 patients with different illness categories and 275 health controls; In vitro IP-10 promoter activity was compared between haplotype GG and AA homozygotes using luciferase reporter system in HepG2 cells. In vivo expression of IP-10 was compared between patients with -201 AA genotype and GG genotype. RESULTS: The detected frequency of G-201A SNP was 17.8%, 25.3%, 26.6%, and 13.8% for patients with acute hepatitis B (AHB), patients with mild chronic hepatitis B (CHB-M), patients with severe chronic hepatitis B (CHB-S), and health controls, respectively. In vitro IP-10 promoter-driven luciferase activity in pGL3-Enhancer-201A transfected HepG2 cells was 1.43-fold higher than that in pGL3-Enhancer-201G transfected HepG2 cells (P<0.01). In vivo IP-10 transcriptional expression of peripheral blood mononuclear cells was 1.38-fold higher in patients with -201 AA genotype than in patients with -201 GG genotype (P<0.01). CONCLUSION: G-201A in promoter region of IP-10 gene was associated with liver disease progression in patients with HBV infection through up-regulating IP-10 expression.
|
Authors | Zhihui Xu, Yan Liu, Liming Liu, Xiaodong Li, Siyu Bai, Yihui Rong, Haibin Wang, Yuanli Mao, Shaojie Xin, Dongping Xu |
Journal | PloS one
(PLoS One)
Vol. 8
Issue 9
Pg. e72799
( 2013)
ISSN: 1932-6203 [Electronic] United States |
PMID | 24023775
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CXCL10 protein, human
- Chemokine CXCL10
|
Topics |
- Adult
- Asian People
(genetics)
- Chemokine CXCL10
(genetics)
- Female
- Genetic Predisposition to Disease
- Hepatitis B
(genetics)
- Humans
- Male
- Polymorphism, Genetic
(genetics)
- Young Adult
|